SCHEMBL19670633

SCHEMBL19670633

Cc1ccc(NC(O)N2c3nc(-c4ccnc(C)c4)ccc3N3CC[C@H]2C3)cn1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ WNT3A P56704 8/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ ABL1 P00519 1/20 0.32
▸ PIK3CA P42336 3/20 0.32
▸ MTOR P42345 3/20 0.32
▸ SCD O00767 2/20 0.32
▸ PRKD1 Q15139 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ MAP4K4 O95819 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PSEN1 P49768 1/20 0.31
▸ PSEN2 P49810 1/20 0.31
▸ APH1B Q8WW43 1/20 0.31
▸ NCSTN Q92542 1/20 0.31
▸ APH1A Q96BI3 1/20 0.31
▸ PSENEN Q9NZ42 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19670538 0.91 ROCK1 (0.34) WNT3AHRH3MAPK1MAP4K4
SCHEMBL19706212 0.89 HRH3 (0.34) HRH3MAPK1PRKD1MAP4K4PIM1
SCHEMBL19670355 0.88 PIM1 (0.37) MAPK1PIM1
SCHEMBL19670625 0.87 HRH3 (0.33) HRH3MAPK1SCDMAP4K4
SCHEMBL19670481 0.87 KARS1 (0.41) HRH3MAPK1PRKD1
SCHEMBL19706138 0.85 WNT3A (0.33) WNT3AHRH3MAPK1ABL1
SCHEMBL19706928 0.84 HRH3 (0.33) WNT3AHRH3MAPK1SCDMAP4K4
SCHEMBL19670504 0.82 MAPK1 (0.32) HRH3MAPK1PIM1
SCHEMBL19706215 0.82 MAP4K4 (0.34) MAP4K4
SCHEMBL17768108 0.81 WNT3A (0.43) WNT3AABL1PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2020-03-17 — — US disclosed
US-20170355697-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2017-12-14 — — US disclosed
US-9834558-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-12-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355697-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 WNT3A 4291/4885HRH3 2288/4885MAPK1 2404/4885
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators SIRT1, SIRT3, SIRT2 WNT3A 4291/4885HRH3 2288/4885MAPK1 2404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback